Studies on rodent models have displayed that insulin resistance may result in a reduction in surface dopamine transporters [114] and reduced insulin-dependent dopamine release in the striatum [115], giving an explanation of higher motor progression and dopamine-transporter deficit found in T2DM patients. This evidence concerns the gene SLC6A3 and Insulin resistance.